Xbrane Biopharma AB (DE:7XB)
BERLIN:7XB
Germany Market

Xbrane Biopharma AB (7XB) Cash flow

1 Followers

Xbrane Biopharma AB Cash Flow

DE:7XB's free cash flow for Q4 2022 was kr-124.46M. For the 2022 fiscal year, DE:7XB's free cash flow was decreased by kr42.92M and operating cash flow was kr-115.06M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
kr -193.92Mkr -193.92Mkr -219.61Mkr -238.41Mkr -148.59Mkr 46.71M
Investing Cash Flow
kr -60.13Mkr -60.13Mkr -77.35Mkr -3.85Mkr -1.19Mkr -1.60M
Financing Cash Flow
kr 148.86Mkr 148.86Mkr 349.37Mkr 322.72Mkr 216.04Mkr 47.73M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
kr 910.77Mkr 193.99Mkr 295.18Mkr 243.14Mkr 164.20Mkr 100.97M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
kr 170.55Mkr 170.55Mkr 380.87Mkr 346.45Mkr 252.46Mkr 3.25M
Issuance Of Debt
----kr 0.00kr 45.00M
Repayment Of Debt
-kr 0.00kr 0.00kr -12.00Kkr -140.00Kkr -131.00K
Free Cash Flow
kr -254.04Mkr -254.04Mkr -296.96Mkr -242.26Mkr -149.78Mkr 45.11M
Domestic Sales
------
Foreign Sales
------
Currency in SEK

Xbrane Biopharma AB Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis